Investments
20Portfolio Exits
1
Want to inform investors similar to DNA Capital about your company?
Submit your Analyst Briefing to get in front of investors, customers, and partners on CB Insights’ platform.
Latest DNA Capital News
Apr 2, 2022
12h agoVenture CapitalvcnewsdailyViews: 51 MINNEAPOLIS, MN, Reema Health, a community-based health technology platform, recently earned $8M in a funding round led by MaC Venture Capital and DNA Capital. Not a member yet? Breaking News 24/7/365 ALL ALPHAMAVEN CONTENT IS FOR INFORMATIONAL PURPOSES ONLY.CONTENT POSTED BY MEMBERS DOES NOT NECESSARILY REFLECT THE OPINION OR BELIEFS OF ALPHAMAVEN AND HAS NOT ALWAYS BEEN INDEPENDENTLY VERIFIED BY ALPHAMAVEN.PAST PERFORMANCE IS NOT INDICATIVE OF FUTURE RESULTS.THIS IS NOT A SOLICITATION FOR INVESTMENT.THE MATERIAL PROVIDED HEREIN IS FOR INFORMATIONAL PURPOSES ONLY.IT DOES NOT CONSTITUTE AN OFFER TO SELL OR A SOLICITATION OF AN OFFER TO BUY ANY INTERESTS OF ANY FUND OR ANY OTHER SECURITIES.ANY SUCH OFFERINGS CAN BE MADE ONLY IN ACCORDANCE WITH THE TERMS AND CONDITIONS SET FORTH IN THE INVESTMENT'S PRIVATE PLACEMENT MEMORANDUM.PRIOR TO INVESTING, INVESTORS ARE STRONGLY URGED TO REVIEW CAREFULLY THE PRIVATE PLACEMENT MEMORANDUM (INCLUDING THE RISK FACTORS DESCRIBED THEREIN), THE LIMITED PARTNERSHIP AGREEMENT AND THE SUBSCRIPTION DOCUMENTS, TO ASK SUCH QUESTIONS OF THE INVESTMENT MANAGER AS THEY DEEM APPROPRIATE, AND TO DISCUSS ANY PROSPECTIVE INVESTMENT IN THE FUND WITH THEIR LEGAL AND TAX ADVISERS IN ORDER TO MAKE AN INDEPENDENT DETERMINATION OF THE SUITABILITY AND CONSEQUENCES OF AN INVESTMENT. ALPHAMAVEN
DNA Capital Investments
20 Investments
DNA Capital has made 20 investments. Their latest investment was in Beep Saude as part of their Series C on November 11, 2022.
DNA Capital Investments Activity
Date | Round | Company | Amount | New? | Co-Investors | Sources |
|---|---|---|---|---|---|---|
11/3/2022 | Series C | Beep Saude | No | 4 | ||
4/1/2022 | PIPE | Anima Educacao | $202.6M | Yes | 1 | |
3/30/2022 | Seed VC - III | Reema Health | $8M | Yes | DNA Capital, and Mac Ventures | 2 |
3/10/2022 | Series A | |||||
3/9/2022 | Private Equity |
Date | 11/3/2022 | 4/1/2022 | 3/30/2022 | 3/10/2022 | 3/9/2022 |
|---|---|---|---|---|---|
Round | Series C | PIPE | Seed VC - III | Series A | Private Equity |
Company | Beep Saude | Anima Educacao | Reema Health | ||
Amount | $202.6M | $8M | |||
New? | No | Yes | Yes | ||
Co-Investors | DNA Capital, and Mac Ventures | ||||
Sources | 4 | 1 | 2 |
DNA Capital Portfolio Exits
1 Portfolio Exit
DNA Capital has 1 portfolio exit. Their latest portfolio exit was Feegow Clinic on July 21, 2022.
Date | Exit | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Acquirer | Sources |
|---|---|---|---|---|---|
7/21/2022 | Acquired | 1 |
Date | 7/21/2022 |
|---|---|
Exit | Acquired |
Companies | |
Valuation | |
Acquirer | |
Sources | 1 |
DNA Capital Acquisitions
2 Acquisitions
DNA Capital acquired 2 companies. Their latest acquisition was Memed on April 29, 2021.
Date | Investment Stage | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Total Funding | Note | Sources |
|---|---|---|---|---|---|---|
4/29/2021 | Private Equity | $22.52M | Acq - Fin | 3 | ||
10/25/2018 |
Date | 4/29/2021 | 10/25/2018 |
|---|---|---|
Investment Stage | Private Equity | |
Companies | ||
Valuation | ||
Total Funding | $22.52M | |
Note | Acq - Fin | |
Sources | 3 |
DNA Capital Team
4 Team Members
DNA Capital has 4 team members, including , .
Name | Work History | Title | Status |
|---|---|---|---|
Alexis Labrecque | Founder | Current | |
Name | Alexis Labrecque | |||
|---|---|---|---|---|
Work History | ||||
Title | Founder | |||
Status | Current |
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.